Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion wasGeneratedBy ECO_0000203 NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion wasDerivedFrom befree-2016 NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion SIO_000772 20387067 NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion evidence source_evidence_literature NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.
- NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_assertion description "[We questioned whether the dual SRC/ABL kinase inhibitor dasatinib can affect AML cells and whether differences can be observed with normal CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805781.RAdjxIG7_anTJoxbtOvYoj5Q8G7mXcBuvXFVBC-WqQhSQ130_provenance.